The pharmacokinetics, pharmacodynamics and safety of the direct factor Xa inhibitor, otamixaban, with and without concomitant acetylsalicylic acid (ASA) were investigated in healthy volunteers...
Keywords: Acetylsalicylic acid, Coagulation, factor Xa, pharmacokinetics, pharmacodynamics, o
00/0000 | Thrombosis and Haemostasis, Schattauer